Related Interviews

A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju

Clinical Data and M&A Serve as Catalysts in 2019
March 22, 2019
Roy, Soumit

Big Pharma Looking to Small-Cap Biotechs for Innovation
March 15, 2019
Vandermosten, John

The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj

Looking for Strong Businesses That Are Utilizing Platforms and Data Analytics
October 05, 2018
Auxier, J. Jeffrey

Relatively Healthy Valuations for Development-Stage Companies
October 02, 2018
Nierengarten, David

Managing U.S. Growth Stocks Across the Market-Cap Spectrum
August 24, 2018
Muggia, William A.

Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj

Investing in Biotech Companies with Free Cash Flow and a Research Focus
December 28, 2017
Auxier, J. Jeffrey

Understanding What You Own and Investing in Enduring Businesses
June 30, 2017
Auxier, J. Jeffrey

Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj

Using Intangible Assets to Identify Undervalued Stocks
March 24, 2017
Dhingra, Gautam

A Cautious Perspective on the Biotechnology Sector
March 10, 2017
Shrader, Thomas

Generating Good After-Tax Returns with High-Conviction Ideas
March 10, 2017
Wallace, Scott

Looking for Change in the Large-Cap Universe
December 30, 2016
Crawford, Kenneth, James, Meghan

Finding Undervalued Assets in the Biotech Sector
November 18, 2016
Adams, Douglas N.

Focusing on the Power of Compounding
November 04, 2016
Auxier, J. Jeffrey

Investing for the Long Term in Biotechnology
October 21, 2016
Webb, Dallas

Critical Demand for Innovation in Pharma and Biotech
August 12, 2016
Brozak, Steve

Innovation and True Technology Solutions Key to Health Care IT Success
October 23, 2015
Rubis, Steve

Applying a Systematic Process to Outperform Over Time
January 20, 2015

Stretched Valuations in Biotech Require Cautious Approach
December 15, 2014

Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014

Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014

Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014

Biotech Space Concentrates on Gene Therapy, CAR T-Cell Technology Side
July 23, 2014

A Large-Cap Growth Strategy Centered on Profit Sustainability and Secular Tailwinds
June 10, 2014

A Balanced Yet Flexible Approach to Investing as the U.S. Economy Improves
February 24, 2014

Pursuing Global Growth Equities
February 18, 2014

Investing in Durable Secular Growth Themes
February 14, 2014

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013

Investing in Health Care Innovation
April 30, 2013

A Health Sciences Fund with a Long-Term Focus
April 22, 2013

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013

Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013

Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013

Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012

Innovation In Cardiovascular And Hepatic Devices And Drugs - Duane Nash - Wedbush Securities
November 21, 2011

Defensive Plays In The Defense Space - Michael F. Ciarmoli - Keybanc Capital Markets Inc.
November 14, 2011

Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011

Technology Enablers Monetize Platform Shifts - Kerry Rice - Wedbush Securities
April 04, 2011

Internet Interactivity Trends In 2011 - Brian J. Pitz - Ubs Investment Bank
April 04, 2011

Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011

An Eye On Value & Long-term Growth In Health Services - Dr. Alastair Mackay - Garp Research & Securities
November 15, 2010

Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010

A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010

Investing In Commodities & Resources - James J. Puplava - Puplava Financial Services, Inc
November 02, 2009

INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008

Absolute Value Investing In Large Cap Stocks - David Fleer & Jean-luc Nouzille - Bristlecone Value Partners, Llc
January 07, 2008

INVESTING IN NORTH AMERICAN VALUE STOCKS - IAN STERLING - P.J. DOHERTY & ASSOCIATES COMPANY LTD.
November 20, 2006

H.HOROWITZ / J.ORRICO - WATER ISLAND CAPITAL LLC
August 14, 2006

ROUNDTABLE FORUM: GAMING
July 10, 2006

STEPHEN PATTEN - SECTORAL ASSET MANAGEMENT INC
February 27, 2006

CABLE & INTEGRATED ENTERTAINMENT COMPANIES: CHRISTOPHER MARANGI - GABELLI & CO INC
November 21, 2005

L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005

EMERGING GROWTH LIFE SCIENCES COMPANIES: KEAY NAKAE - C.E. UNTERBERG, TOWBIN
October 25, 2005

JOE BRUENING - RENAISSANCE INVESTMENT MANAGEMENT
October 17, 2005

DEREK TANER - AIM INVESTMENTS
July 18, 2005

MID-TIER GOLD PRODUCERS: PAUL O'BRIEN - RAYMOND JAMES LTD
June 27, 2005

K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005

ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005

K.STRAUSS / C.ZWEIG - ABNER HERMAN & BROCK INC ASSET MANAGEMENT
March 28, 2005

JOSEPH COSTIGAN - DAVIDSON CAPITAL MANAGEMENT INC
December 20, 2004

SAM KATZ - WELLSPRING BIOCAPITAL PARTNERS
November 22, 2004

INVESTING IN SUNBELT COMMUNITY BANKS: J.DEMBA / G.TENNER - SUNTRUST ROBINSON HUMPHREY
September 28, 2004

OUTLOOK FOR PAPER & FOREST PRODUCTS: STEVE CHERCOVER - D.A.DAVIDSON & CO
September 20, 2004

SPECIALTY PHARMACEUTICALS & DRUG DELIVERY: LOUIS WEBB - WR HAMBRECHT & CO
September 06, 2004

KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004

DATA STORAGE & SERVICES: DANIEL RENOUARD - ROBERT W. BAIRD & CO
March 08, 2004

NANCY HOLLAND - ABN AMRO ASSET MANAGEMENT (USA) LLC
February 23, 2004

D.ALTABEF / D.KATZ - MATRIX ASSET ADVISORS
January 26, 2004